XML 80 R69.htm IDEA: XBRL DOCUMENT v3.25.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Feb. 14, 2025
Feb. 13, 2025
Nov. 07, 2024
Nov. 06, 2024
Jun. 24, 2024
Jan. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Mar. 31, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
May 06, 2025
Mar. 06, 2025
Mar. 05, 2025
Dec. 20, 2024
Subsidiary or Equity Method Investee [Line Items]                                
Share price                           $ 0.10 $ 0.10  
Issuance of shares               $ 2,529,449                
Net proceeds of June 2024 private placement equity offering with detachable warrants     $ 2,669,250             $ 2,194,742          
Issuance of stock, value                       $ 3,600,000        
Deduction costs of offering     $ 330,750                          
Shares of common stock were exercised                              
Net loss (income) attributable to noncontrolling interests             $ 55,997 73,310   $ 59,608 $ 61,063          
Nobility Healthcare LLC [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Subsidiary ownership percentage             49.00%     49.00%            
Net loss (income) attributable to noncontrolling interests             $ 55,997 $ 73,310   $ 59,608 $ 61,063          
Nobility Healthcare LLC [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Equity method investment ownership percentage             51.00%     51.00%            
Officers [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Common stock issuance granted           27                    
Vesting drescription           Such shares will generally vest over a period of one to five years on their respective anniversary dates in January through January 2028, provided that each grantee remains an officer or employee on such dates.                    
New Employees [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Common stock issuance granted           13                    
New Employees [Member] | Minimum [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Vesting period           1 year                    
New Employees [Member] | Maximum [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Vesting period           2 years                    
Employees [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Cancellation of restricted stock, shares                   0 1          
Private Placement [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Issuance of stock, shares         60                      
Share price         $ 5,020.00                      
Pre-funded unit price         $ 0.001                      
Common Stock [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Issuance of stock, shares               311                
Share price                               $ 1.00
Issuance of shares               $ 1                
Common stock issuance granted                 40              
Cancellation of restricted stock, shares                 1              
Series B Warrants [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Warrant shares                         1,669,357      
Shares of common stock were exercised             1,897     1,897            
Shares of common stock were exercised, value             $ 3,793                  
Fair value of warrant derivative liability             $ 1,989,806     $ 1,989,806            
Prefunded Warrants [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Exercise price             $ 0.001     $ 0.001            
Shares of common stock were exercised             49,075     49,075            
Underwriting Agreement [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Net proceeds from offering $ 13,480,000                              
Underwriting Agreement [Member] | Over-Allotment Option [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Issuance of shares $ 14,308,300                              
Underwriting Agreement [Member] | Common Stock [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Offering percentage 15.00%                              
Underwriting Agreement [Member] | Common Stock [Member] | Over-Allotment Option [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Issuance of stock, shares 3,000                              
Underwriting Agreement [Member] | Series A Warrants [Member] | Underwriting Discount [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Share price $ 0.00001                              
Underwriting Agreement [Member] | Series A Warrants [Member] | Over-Allotment Option [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Share price $ 0.00001                              
Warrant shares 7,500                              
Underwriting Agreement [Member] | Series B Warrants [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Offering percentage 15.00%                              
Underwriting Agreement [Member] | Series B Warrants [Member] | Underwriting Discount [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Share price $ 0.00001                              
Underwriting Agreement [Member] | Series B Warrants [Member] | Over-Allotment Option [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Share price $ 0.00001                              
Warrant shares 7,500                              
The Securities Purchase Agreement [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Net proceeds of June 2024 private placement equity offering with detachable warrants         $ 2,900,000                      
Securities Purchase Agreement [Member] | Private Placement [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Net proceeds of June 2024 private placement equity offering with detachable warrants       $ 3,000,000.0                        
Issuance of stock, value       $ 3,600,000                        
Issuance of stock, shares       404                        
Securities Purchase Agreement [Member] | Common Stock [Member] | Private Placement [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Issuance of stock, shares       404                        
Aegis Capital Corp [Member] | Underwriting Agreement [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Issuance of stock, shares   3,925                            
Share price   $ 300.00                            
Aggregate purchase price percentage 7.00%                              
Legal fees percentage 1.00%                              
Aegis Capital Corp [Member] | Underwriting Agreement [Member] | Series A Warrants [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Exercise price   375.00                            
Aegis Capital Corp [Member] | Underwriting Agreement [Member] | Series B Warrants [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Exercise price   $ 600.00                            
Aegis Capital Corp [Member] | Underwriting Agreement [Member] | Prefunded Warrants [Member]                                
Subsidiary or Equity Method Investee [Line Items]                                
Issuance of stock, shares   46,075                            
Share price   $ 298.00                            
Exercise price   $ 0.001